Adherence to desferrioxamine and deferiprone and the impact of deferiprone co-prescription in thalassaemia major patients. Does the addition of deferiprone improve adherence?

British Journal of Haematology

Volumn 142, Issue 4, 2008, Pages 679-680

  Kidson Gerber, Giselle ^a   Lindeman, Robert ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Adherence; Deferiprone; Desferrioxamine; Iron chelation; Thalassaemia major

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN;

ADULT; BLOOD TRANSFUSION; CHELATION THERAPY; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HOSPITAL PHARMACY; HUMAN; IRON CHELATION; IRON OVERLOAD; LETTER; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; THALASSEMIA MAJOR;

BETA-THALASSEMIA; DEFEROXAMINE; DRUG THERAPY, COMBINATION; HUMANS; IRON CHELATING AGENTS; PATIENT COMPLIANCE; PYRIDONES; SIDEROPHORES;

EID: 47649096634     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07234.x     Document Type: Letter

References (7)

1. Cappellini, M.D. (2005) Overcoming the challenge of patient compliance with iron chelation therapy. Seminars in Hematology, 42 2 Suppl 1 S19 S21.
2. Gamberini, M.R., Fortini, M., De Sanctis, V., Gilli, G. Testa, M.R. (2004) Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center. Pediatric Endocrinology Reviews, 2 (Suppl. 2 285 291.
3. Haynes, R.B., Ackloo, E., Sahota, N., McDonald, H.P. Yao, X. (2005) Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews, 4, 1 16.
4. Olivieri, N.F. (2004) Adherence to deferoxamine therapy; heeding Hippocrates and Osler. American Journal of Hematology, 76, 415 416.
5. Vermiere, E. (2001) Patient adherence to therapy: 3 decades of research. Journal of Clinical Pharmacology & Therapeutics, 26, 331 342.
6. Ward, A., Caro, J.J., Green, T.C., Huybrechts, K., Arana, A., Wait, S. Eleftheriou, A. (2002) An International survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use. BMC Clinical Pharmacology, 2, 3.
7. World Health Organization 2003) Adherence to Long-Term Therapies, Evidence for Action. World Health Organisation, Geneva, Switzerland. ISBN 92 4 154599 2.